bioMérieux
Ayman Khalifa is a seasoned professional with extensive experience in quality management and regulatory affairs within the pharmaceutical industry. Currently serving as a Quality Expert in Global Commercial Operations Excellence at bioMérieux since January 2020, Ayman has previously held various leadership roles at GSK from July 2013 to December 2019, including Quality and Regulatory Compliance Section Head, where responsibilities included managing the internal audit process and overseeing Corrective and Preventive Actions (CAPAs). Ayman’s career began with positions such as Quality Control Analyst at Hikma Pharmaceuticals and Community Pharmacist at Seif Group. Ayman holds a Bachelor of Pharmacy from Cairo University and is pursuing an MBA at the Arab Academy for Science, Technology and Maritime Transport.
This person is not in any teams
This person is not in any offices
bioMérieux
20 followers
Biomerieux SA is a France-based company that specializes in the field of in-vitro diagnostics for medical and industrial applications. The Company designs, develops, manufactures and sells systems used in clinical applications, such as for the diagnosis of tuberculosis, respiratory infections, among others and industrial applications, such as for the analysis of industrial or environmental samples. The Company also provides its customers with related services for the installation and maintenance of instruments, and training for product users. BioMerieux SA operates through its numerous subsidiaries in various countires, including bioMerieux Deutschland GmbH, bioMerieux Austria GmbH, Advencis, bioMerieux Benelux SA/NV, as well as BioFire Diagnostics Inc., chromID CARBA SMART and new bi-plate Petri dish.